Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 21353695

Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet
Publication date
2011 Mar 5
First author
Fizazi K

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet. 2011 Mar 5;377(9768):785-6. doi: 10.1016/S0140-6736(11)60100-1.
    note
    Source null
    related pmid
    21353698
    relationship
    Comment in
  2. citation
    Asian J Androl. 2011 Jul;13(4):612-3. doi: 10.1038/aja.2011.33.
    note
    Source null
    related pmid
    21499282
    relationship
    Comment in
  3. citation
    J Urol. 2011 Dec;186(6):2254-5. doi: 10.1016/j.juro.2011.08.108.
    note
    Source null
    related pmid
    22078585
    relationship
    Comment in

Authors and identifiers

  1. name
    Fizazi K
    type
    Author
  2. name
    Carducci M
    type
    Author
  3. name
    Smith M
    type
    Author
  4. name
    Damião R
    type
    Author
  5. name
    Brown J
    type
    Author
  6. name
    Karsh L
    type
    Author
  7. name
    Milecki P
    type
    Author
  8. name
    Shore N
    type
    Author
  9. name
    Rader M
    type
    Author
  10. name
    Wang H
    type
    Author
  11. name
    Jiang Q
    type
    Author
  12. name
    Tadros S
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Fizazi K
    type
    Author
  2. name
    Carducci M
    type
    Author
  3. name
    Smith M
    type
    Author
  4. name
    Damião R
    type
    Author
  5. name
    Brown J
    type
    Author
  6. name
    Karsh L
    type
    Author
  7. name
    Milecki P
    type
    Author
  8. name
    Shore N
    type
    Author
  9. name
    Rader M
    type
    Author
  10. name
    Wang H
    type
    Author
  11. name
    Jiang Q
    type
    Author
  12. name
    Tadros S
    type
    Author
bibliography ids
  1. nci-bib-86368889091e3a84f9173395
book metadata
content sha256
de315184149948cf06526c30f650b31d6c250c6479ede904170c91de0da3bb88
document type
citation
dois
  1. 10.1016/S0140-6736(10)62344-6
electronic publication date
display
2011 Feb 25
precision
day
year
2011
evidence scope
bibliographic_metadata_only
id
pubmed:21353695
immutable id
pubmed:21353695@de315184149948cf06526c30f650b31d6c250c6479ede904170c91de0da3bb88
journal
abbreviation
Lancet
issn electronic
1474-547X
issn print
0140-6736
issue
9768
name
Lancet (London, England)
nlm unique id
2985213R
pages
813-22
volume
377
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet. 2011 Mar 5;377(9768):785-6. doi: 10.1016/S0140-6736(11)60100-1.
    note
    Source null
    related pmid
    21353698
    relationship
    Comment in
  2. citation
    Asian J Androl. 2011 Jul;13(4):612-3. doi: 10.1038/aja.2011.33.
    note
    Source null
    related pmid
    21499282
    relationship
    Comment in
  3. citation
    J Urol. 2011 Dec;186(6):2254-5. doi: 10.1016/j.juro.2011.08.108.
    note
    Source null
    related pmid
    22078585
    relationship
    Comment in
outcomes validated
false
pmid
21353695
provenance
batch id
edef4b7f1a2a505cd5a9
provider
NCBI PubMed ESummary
record sha256
e7e11fe17b86c48cb226c05ecf24a8377d84286ad265c5edaaab361b951f0af7
response sha256
d2d0fd7c34783716c953156f8a1da1b7b36c4823b416656eca04a1e69e03a295
retrieved at
2026-09-09T23:46:38.027615+00:00
publication date
display
2011 Mar 5
precision
day
year
2011
publication types
  1. Clinical Trial, Phase III
  2. Comparative Study
  3. Journal Article
  4. Multicenter Study
  5. Randomized Controlled Trial
  6. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/21353695/
title
Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study.

Preserved source evidence · Not medical advice